In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques

Atherosclerosis

Volumn 150, Issue 2, 2000, Pages 343-355

  Imanaga, Yoshinobu ^a   Sakata, Noriyuki ^a   Takebayashi, Shigeo ^a   Matsunaga, Akira ^a   Sasaki, Jun ^a   Arakawa, Kikuo ^a   Nagai, Ryoji ^b   Horiuchi, Seikoh ^b   Itabe, Hiroyuki ^c   Takano, Tatsuya ^c  

^a FUKUOKA UNIVERSITY   (Japan)

^b KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^c TEIKYO UNIVERSITY   (Japan)

Author keywords

Atherogenesis; ELISA; Glycoxidation of LDL; Immunohistochemistry; N( ) (carboxymethyl)lysine (CML) protein adduct; Oxidized phosphatidylcholine

Indexed keywords

EPITOPE; LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE;

ADULT; AGED; AORTA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CADAVER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; LIPID OXIDATION; MALE; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; AORTIC DISEASES; ARTERIOSCLEROSIS; CHELATING AGENTS; CHILD; CHILD, PRESCHOOL; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; GUANIDINES; HUMANS; INFANT; LIPOPROTEINS, LDL; LYSINE; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLCHOLINES; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0034117018     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00396-2     Document Type: Article

References (38)

1. Vlassara H., Bucala R., Striker L. Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab. Invest. 70:1994;138-151.
2. Sakata N., Imanaga Y., Meng J., Tachikawa Y., Takebayashi S., Nagai R. et al. Immunohistochemical localization of different epitopes of advanced glycation end products in human atherosclerotic lesions. Atherosclerosis. 141:1998;61-75.
3. Palinski W., Koschinsky T., Butler S.W., Miller E., Vlassara H., Cerami A. et al. Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits. Arterioscler. Thromb. Vasc. Biol. 15:1995;571-582.
4. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes. 40:1991;405-412.
5. ε-(carboxymethyl)lysine in human tissues in diabetes and aging. J. Clin. Invest. 99:1997;457-468.
6. Meng J., Sakata N., Takebayashi S., Asano T., Futata T., Nagai R. et al. Glycoxidation in aortic collagen from STZ-induced diabetic rats and its relevance to vascular damage. Atherosclerosis. 136:1998;355-365.
7. Odetti P., Pronzato M.A., noberasco G., Cosso L., Traverso N., Cottalasso D. et al. Relationships between glycation and oxidation-related fluorescences in rat collagen during aging. Lab. Invest. 70:1994;61-67.
8. Sakurai T., Kimura S., Nakano M., Kimura H. Oxidative modification of glycated low density lipoprotein in the presence of iron. Biochem. Biophys. Res. Comm. 177:1991;433-439.
9. Kawamura M., Heinecke J.W., Chait A. Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway. J. Clin. Invest. 94:1995;771-778.
10. Sakurai T., Tsuchiya S. Superoxide production from nonenzymatically glycated protein. FEBS Lett. 236:1988;406-410.
11. ε-(carboxymethyl)lysine as a degradation product of fructoselysine in glycated protein. J. Biol. Chem. 261:1986;4889-4894.
12. ε-(carboxymethyl)lysine formation from Amadori product. Biochem. Biophys. Res. Comm. 234:1997;167-172.
13. Kume S., Takeya M., Mori T., Araki N., Suzuki H., Horiuchi S. et al. Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody. Am. J. Pathol. 147:1995;654-667.
14. Sakata N., Imanaga Y., Meng J., Tachikawa Y., Takebayashi S., Nagai R. et al. Increased advanced glycation end products in atherosclerotic lesions of patients with end-stage renal disease. Atherosclerosis. 142:1999;67-77.
15. Itabe H., Takeshima E., Iwasaki H., Kimura J., Yoshida Y., Imanaka T. et al. A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. J. Biol. Chem. 269:1994;15274-15279.
16. Itabe H., Yamamoto H., Imanaka T., Shimamura K., Uchiyama H., Kimura J. et al. Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody. J. Lipid. Res. 37:1996;45-53.
17. Horiuchi S., Araki N., Morino Y. Immunochemical approach to characterize advanced glycation end products of the Maillard reaction: evidence for the presence of a common structure. J. Biol. Chem. 266:1991;7329-7332.
18. ε-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry. 35:1996;8075-8083.
19. Radgrave T.G., Rogert D.C.K., West C.E. Separation of plasma lipoproteins by density gradient ultracentrifugation. Anal. Biochem. 65:1975;42-49.
20. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95:1979;351-358.
21. Johnson R.N., Metcalf P.A., Baker J.R. Fructosamine: a new approach to the estimation of serum glycosylation. An index of diabetic control. Clin. Chim. Acta. 127:1982;87-95.
22. Sell D.R., Monnier V.M. Structure elucidation of a senescence cross-link from human extracellular matrix: implication of pentoses in aging process. J. Biol. Chem. 264:1989;21597-21602.
23. Hayase F., Nagaraj R.H., Miyata S., Njoroge F.G., Monnier V.M. Aging of proteins: immunological detection of a glucose-derived pyrrole formed during Maillard reaction in vivo. J. Biol. Chem. 264:1989;3758-3764.
24. Dyer D.G., Blackledge J.A., Thorpe S.R., Baynes J.W. Formation of pentosidine during nonenzymatic browning of protein by glucose: identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. J. Biol. Chem. 266:1991;11654-11660.
25. Ikeda K., Nagai R., Sakamoto T., Sano H., Araki T., Sakata N. et al. Immunochemical approaches to AGE-structures: characterization of anti-AGE antibodies. J. Immunol. Methods. 215:1998;95-104.
26. Endemann G., Stanton L.W., Maddem K.S., Bryant C.M., White R.T., Protter A.A. CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 269:1993;11811-11816.
27. Freeman M.Y., Ekkel Y., Rohrer L., Penmen M., Freeman N.J., Chisolm G.M. et al. Expression of type I and type II bovine scavenger receptors in Chinese hamster ovary cells: lipid proplet accumulation and nonreciprocal cross competition by acetylated and oxidized low density lipoprotein. Proc. Natl. Acad. Sci. USA. 88:1991;4931-4935.
28. Palinski W., Rosenfeld M.E., Yla-Herittuala S., Gurtner G.C., Socher S.S., Butler S.W. et al. Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA. 86:1989;1372-1376.
29. Reiser K.M. Nonenzymatic glycation of collagen in aging and diabetes: minireview. Proc. Soc. Exp. Biol. Med. 196:1991;17-29.
30. Brownlee M., Vlassara H., Cerami A. Nonenzymatic glycosylation products on collagen covalently trap low-density lipoprotein. Diabetes. 34:1985;938-941.
31. Wells-Knecht K.J., Zyzak D.V., Litchfield J.E., Thorpes S.R., Baynes J.W. Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry. 34:1995;3702-3709.
32. Requena J.R., Fu M.X., Ahmed M.U., Jenkins A.J., Lyons T.J., Thorpe S.R. Lipoxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions. Nephrol. Dial. Transplant. 11(Suppl 5):1996;48-53.
33. Glomb M.A., Monnier V.M. Mechanism of protein modification by glyoxal and glycoaldehyde, reactive intermediates of the Maillard reaction. J. Biol. Chem. 270:1995;10017-10026.
34. Wells-Knecht M.C., Thorpe S.R., Baynes J.W. Pathways of formation of glycoxidation products during glycation of collagen. Biochemistry. 34:1995;15134-15141.
35. Horie K., Miyata T., Maeda K., Miyata S., Sugiyama S., Sakai H. et al. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. J. Clin. Invest. 100:1997;2995-3004.
36. Yui S., Sasaki T., Araki N., Horiuchi S., Yamasaki M. Induction of macrophage growth by advanced glycation end products of the Maillard reaction. J. Immunol. 152:1994;1943-1949.
37. Goldstein J.L., Ho Y.K., Basu S.K., Brown M.S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA. 76:1979;333-337.
38. Sell D.R., Lapolla A., Odetti P., Fogarty J., Monnier V.M. Pentosidine formation in skin correlates with severity of complication in individuals with long-standing IDDM. Diabetes. 41:1992;1286-1292.